Lineage- and stage-restricted lentiviral vectors for the gene therapy of chronic granulomatous disease

[1]  Kathryn L. Parsley,et al.  Biochemical correction of X-CGD by a novel chimeric promoter regulating high levels of transgene expression in myeloid cells. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[2]  Jérôme Larghero,et al.  Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia , 2010, Nature.

[3]  Hans Martin,et al.  Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease , 2010, Nature Medicine.

[4]  Manfred Schmidt,et al.  Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy , 2009, Science.

[5]  A. Schambach,et al.  Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[6]  Zhixiong Li,et al.  Cell-intrinsic and vector-related properties cooperate to determine the incidence and consequences of insertional mutagenesis. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[7]  M. Hansmann,et al.  Resistance of mature T cells to oncogene transformation. , 2008, Blood.

[8]  D. Duboule,et al.  Genotypic Features of Lentivirus Transgenic Mice , 2008, Journal of Virology.

[9]  C. Baum.  Insertional mutagenesis in gene therapy and stem cell biology , 2007, Current opinion in hematology.

[10]  O. Danos,et al.  Lentiviral vectors targeting WASp expression to hematopoietic cells, efficiently transduce and correct cells from WAS patients , 2007, Gene Therapy.

[11]  A. J. Valente,et al.  Development of a synthetic promoter for macrophage gene therapy. , 2006, Human gene therapy.

[12]  Clelia Di Serio,et al.  Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration , 2006, Nature Biotechnology.

[13]  Yang Du,et al.  Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1 , 2006, Nature Medicine.

[14]  P. Opolon,et al.  A lentiviral vector encoding the human Wiskott–Aldrich syndrome protein corrects immune and cytoskeletal defects in WASP knockout mice , 2005, Gene Therapy.

[15]  F. Bushman,et al.  Retroviral DNA Integration: ASLV, HIV, and MLV Show Distinct Target Site Preferences , 2004, PLoS biology.

[16]  Cameron S. Osborne,et al.  LMO2-Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1 , 2003, Science.

[17]  T. Hawley,et al.  Performance- and safety-enhanced lentiviral vectors containing the human interferon-β scaffold attachment region and the chicken β-globin insulator , 2003 .

[18]  T. Hawley,et al.  Performance- and safety-enhanced lentiviral vectors containing the human interferon-beta scaffold attachment region and the chicken beta-globin insulator. , 2003, Blood.

[19]  L. Naldini,et al.  Lentiviral vectors containing the human immunodeficiency virus type-1 central polypurine tract can efficiently transduce nondividing hepatocytes and antigen-presenting cells in vivo. , 2002, Blood.

[20]  J. Collinge,et al.  Expression Pattern of a Mini Human PrP Gene Promoter in Transgenic Mice , 2002, Neurobiology of Disease.

[21]  Félix Recillas-Targa,et al.  Position-effect protection and enhancer blocking by the chicken β-globin insulator are separable activities , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Kathryn L. Parsley,et al.  High-level transduction and gene expression in hematopoietic repopulating cells using a human imunodeficiency virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter , 2002 .

[23]  David Baltimore,et al.  Germline Transmission and Tissue-Specific Expression of Transgenes Delivered by Lentiviral Vectors , 2002, Science.

[24]  Kathryn L. Parsley,et al.  High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of imunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter. , 2002, Human gene therapy.

[25]  Richard B. Johnston,et al.  Chronic Granulomatous Disease: Report on a National Registry of 368 Patients , 2000, Medicine.

[26]  T. Steinmann,et al.  A Conserved Domain of the Arabidopsis GNOM Protein Mediates Subunit Interaction and Cyclophilin 5 Binding , 2000, Plant Cell.

[27]  H. Malech.  Progress in gene therapy for chronic granulomatous disease. , 1999, The Journal of infectious diseases.

[28]  Luigi Naldini,et al.  Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo , 1997, Nature Biotechnology.

[29]  F. Gage,et al.  In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector , 1996, Science.

[30]  T. Fleisher,et al.  Flow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes. , 1995, Journal of immunological methods.

[31]  David A. Williams,et al.  Mouse model of X–linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production , 1995, Nature Genetics.

[32]  S. Orkin,et al.  Targeting of transgene expression to monocyte/macrophages by the gp91-phox promoter and consequent histiocytic malignancies. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[33]  R. Jaenisch,et al.  A generic intron increases gene expression in transgenic mice , 1991, Molecular and cellular biology.

[34]  J. Gauchat,et al.  Superoxide-dependent nitroblue tetrazolium reduction and expression of cytochrome b-245 components by human tonsillar B lymphocytes and B cell lines. , 1989, Journal of immunology.

[35]  A. Fauci,et al.  B cell lines as models for inherited phagocytic diseases: abnormal superoxide generation in chronic granulomatous disease and giant granules in Chediak-Higashi syndrome. , 1984, Journal of immunology.